SHARE
COPY LINK

NORWAY

Norway plans to roll out saliva tests for coronavirus

The Norwegian Institute of Public Health is planning to roll out saliva tests for coronavirus which will save the public from the unpleasant experience of deep nose and throat swabs.

In an email to the VG newspaper Karoline Bragstad, an acting  section manager at the organisation, said that the agency hoped the new tests would allow it to more rapidly ramp up the number of people tested. 
 
“A saliva test taken by the patient themselves would be able to solve many of the bottlenecks which are stopping us being able to test more people,” she wrote.
 
“If the method proves to work well then it will be much easier to do more tests, we will be able to save on the use of protective equipment and may not be as vulnerable to deliveries of sampling equipment,” she said. 
 
She said that patients often found the current methods of taking coronavirus tests, through a deep throat or nose swab, extremely uncomfortable. 
 
“A test brush is inserted very far into the nose or far back into the throat,” she wrote. “The nose test in particular can be very unpleasant.” 
 
The prospect of saliva tests was first mentioned in the institute's latest risk analysis, published on Wednesday, which estimated that the new testing method could be rolled out “within a few weeks”. 
 
 
A simple saliva test could dramatically reduce the number of testing staff needed, and also save on protective equipment. 
 
The laboratory analysis itself would not need to change, Bragstad said, only the method of collecting samples. 
 
“We are optimistic, but must investigate further that this method is not significantly worse than a deep nose or throat test,” she said. 
 
“It is an obvious goal that people will be able take the test themselves. But many people will still need to be tested in the usual way with a deep nose or throat test so we can also check for diseases other than Covid-19.” 
 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS